Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation

Acute ischemia-reperfusion injury (IRI) of the extremities leads to local and systemic inflammatory changes which can hinder limb function and can be life threatening. This study examined whether the administration of the T-cell sequestration agent, FTY720, following hind limb tourniquet-induced ske...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony D. Foster, Diego Vicente, Jonathan J. Sexton, Luke Johnston, Nick Clark, Crystal Leonhardt, Eric A. Elster, Thomas A. Davis, Matthew J. Bradley
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/4594035
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545441337573376
author Anthony D. Foster
Diego Vicente
Jonathan J. Sexton
Luke Johnston
Nick Clark
Crystal Leonhardt
Eric A. Elster
Thomas A. Davis
Matthew J. Bradley
author_facet Anthony D. Foster
Diego Vicente
Jonathan J. Sexton
Luke Johnston
Nick Clark
Crystal Leonhardt
Eric A. Elster
Thomas A. Davis
Matthew J. Bradley
author_sort Anthony D. Foster
collection DOAJ
description Acute ischemia-reperfusion injury (IRI) of the extremities leads to local and systemic inflammatory changes which can hinder limb function and can be life threatening. This study examined whether the administration of the T-cell sequestration agent, FTY720, following hind limb tourniquet-induced skeletal muscle IRI in a rat model would attenuate systemic inflammation and multiple end organ injury. Sprague-Dawley rats were subjected to 1 hr of ischemia via application of a rubber band tourniquet. Animals were randomized to receive an intravenous bolus of either vehicle control or FTY720 15 min after band placement. Rats (n=10/time point) were euthanized at 6, 24, and 72 hr post-IRI. Peripheral blood as well as lung, liver, kidney, and ischemic muscle tissue was analyzed and compared between groups. FTY720 treatment markedly decreased the number of peripheral blood T cells (p<0.05) resulting in a decreased systemic inflammatory response and lower serum creatinine levels and had a modest but significant effect in decreasing the transcription of injury-associated target genes in multiple end organs. These findings suggest that early intervention with FTY720 may benefit the treatment of IRI of the limb. Further preclinical studies are necessary to characterize the short-term and long-term beneficial effects of FTY720 following tourniquet-induced IRI.
format Article
id doaj-art-698a3896678440f5abd021ad96c2f267
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-698a3896678440f5abd021ad96c2f2672025-02-03T07:25:51ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/45940354594035Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic InflammationAnthony D. Foster0Diego Vicente1Jonathan J. Sexton2Luke Johnston3Nick Clark4Crystal Leonhardt5Eric A. Elster6Thomas A. Davis7Matthew J. Bradley8Department of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USADepartment of Regenerative Medicine, Naval Medical Research Center, Silver Spring, MD, USAAcute ischemia-reperfusion injury (IRI) of the extremities leads to local and systemic inflammatory changes which can hinder limb function and can be life threatening. This study examined whether the administration of the T-cell sequestration agent, FTY720, following hind limb tourniquet-induced skeletal muscle IRI in a rat model would attenuate systemic inflammation and multiple end organ injury. Sprague-Dawley rats were subjected to 1 hr of ischemia via application of a rubber band tourniquet. Animals were randomized to receive an intravenous bolus of either vehicle control or FTY720 15 min after band placement. Rats (n=10/time point) were euthanized at 6, 24, and 72 hr post-IRI. Peripheral blood as well as lung, liver, kidney, and ischemic muscle tissue was analyzed and compared between groups. FTY720 treatment markedly decreased the number of peripheral blood T cells (p<0.05) resulting in a decreased systemic inflammatory response and lower serum creatinine levels and had a modest but significant effect in decreasing the transcription of injury-associated target genes in multiple end organs. These findings suggest that early intervention with FTY720 may benefit the treatment of IRI of the limb. Further preclinical studies are necessary to characterize the short-term and long-term beneficial effects of FTY720 following tourniquet-induced IRI.http://dx.doi.org/10.1155/2017/4594035
spellingShingle Anthony D. Foster
Diego Vicente
Jonathan J. Sexton
Luke Johnston
Nick Clark
Crystal Leonhardt
Eric A. Elster
Thomas A. Davis
Matthew J. Bradley
Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
Mediators of Inflammation
title Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
title_full Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
title_fullStr Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
title_full_unstemmed Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
title_short Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation
title_sort administration of fty720 during tourniquet induced limb ischemia reperfusion injury attenuates systemic inflammation
url http://dx.doi.org/10.1155/2017/4594035
work_keys_str_mv AT anthonydfoster administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT diegovicente administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT jonathanjsexton administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT lukejohnston administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT nickclark administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT crystalleonhardt administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT ericaelster administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT thomasadavis administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation
AT matthewjbradley administrationoffty720duringtourniquetinducedlimbischemiareperfusioninjuryattenuatessystemicinflammation